| Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media A Oikonomopoulos, WK van Deen, AR Manansala, PN Lacey, ... Scientific reports 5 (1), 16570, 2015 | 172 | 2015 |
| MicroRNA214 is associated with progression of ulcerative colitis, and inhibition reduces development of colitis and colitis-associated cancer in mice C Polytarchou, DW Hommes, T Palumbo, M Hatziapostolou, ... Gastroenterology 149 (4), 981-992. e11, 2015 | 141 | 2015 |
| Developing a standard set of patient-centred outcomes for inflammatory bowel disease—an international, cross-disciplinary consensus AH Kim, C Roberts, BG Feagan, R Banerjee, W Bemelman, K Bodger, ... Journal of Crohn's and Colitis 12 (4), 408-418, 2018 | 129 | 2018 |
| A nationwide 2010–2012 analysis of US health care utilization in inflammatory bowel diseases WK van Deen, MGH van Oijen, KD Myers, A Centeno, W Howard, ... Inflammatory bowel diseases 20 (10), 1747-1753, 2014 | 75 | 2014 |
| Development and validation of an inflammatory bowel diseases monitoring index for use with mobile health technologies WK Van Deen, AE van der Meulen-de, NK Parekh, E Kane, A Zand, ... Clinical gastroenterology and hepatology 14 (12), 1742-1750. e7, 2016 | 74 | 2016 |
| Presenteeism in inflammatory bowel diseases: a hidden problem with significant economic impact A Zand, WK van Deen, EK Inserra, L Hall, E Kane, A Centeno, JM Choi, ... Inflammatory bowel diseases 21 (7), 1623-1630, 2015 | 71 | 2015 |
| The impact of value-based healthcare for inflammatory bowel diseases on healthcare utilization: a pilot study WK van Deen, A Spiro, AB Ozbay, M Skup, A Centeno, NE Duran, ... European journal of gastroenterology & hepatology 29 (3), 331-337, 2017 | 57 | 2017 |
| Stem cell therapy in inflammatory bowel disease: which, when and how? WK van Deen, A Oikonomopoulos, DW Hommes Current opinion in gastroenterology 29 (4), 384-390, 2013 | 37 | 2013 |
| Expanded parameters in active surveillance for low-risk papillary thyroid carcinoma: a nonrandomized controlled trial AS Ho, S Kim, C Zalt, ML Melany, IE Chen, J Vasquez, JMS Clair, ... JAMA oncology 8 (11), 1588-1596, 2022 | 35 | 2022 |
| Involving end-users in the design of an audit and feedback intervention in the emergency department setting–a mixed methods study WK van Deen, ES Cho, K Pustolski, D Wixon, S Lamb, TW Valente, ... BMC health services research 19, 1-13, 2019 | 28 | 2019 |
| Value-based health care for inflammatory bowel diseases WK van Deen, E Esrailian, DW Hommes Journal of Crohn's and Colitis 9 (5), 421-427, 2015 | 27 | 2015 |
| Immunomodulatory effects of mesenchymal stromal cells in Crohn’s disease I Molendijk, M Duijvestein, A van der Meulen-de Jong, WK van Deen, ... Journal of allergy 2012, 2012 | 25 | 2012 |
| Anti-TNF antibodies in inflammatory bowel disease: do we finally know how it works? A Oikonomopoulos, W K van Deen, D W Hommes Current drug targets 14 (12), 1421-1432, 2013 | 24 | 2013 |
| Value redefined for inflammatory bowel disease patients: a choice-based conjoint analysis of patients’ preferences WK Van Deen, D Nguyen, NE Duran, E Kane, MGH van Oijen, ... Quality of life research 26, 455-465, 2017 | 22 | 2017 |
| Development and pilot testing of the inflammatory bowel disease nutrition care pathway C Hwang, K Issokson, C Giguere-Rich, S Reddy, A Tinsley, WK Van Deen, ... Clinical Gastroenterology and Hepatology 18 (12), 2645-2649. e4, 2020 | 20 | 2020 |
| The effects of inflammatory bowel disease on caregivers: significant burden and loss of productivity A Zand, BJ Kim, WK van Deen, Z Stokes, A Platt, S O’Hara, H Khong, ... BMC health services research 20, 1-10, 2020 | 19 | 2020 |
| Artificial intelligence for inflammatory bowel diseases (IBD); accurately predicting adverse outcomes using machine learning A Zand, Z Stokes, A Sharma, WK van Deen, D Hommes Digestive Diseases and Sciences 67 (10), 4874-4885, 2022 | 15 | 2022 |
| Quality of care program reduces unplanned health care utilization in patients with inflammatory bowel disease GY Melmed, B Oliver, JK Hou, D Lum, S Singh, D Crate, C Almario, ... Official journal of the American College of Gastroenterology| ACG 116 (12 …, 2021 | 13 | 2021 |
| Organizational factors associated with practitioners’ support for treatment of opioid use disorder in the emergency department E Guerrero, AJ Ober, DL Howard, T Khachikian, Y Kong, WK van Deen, ... Addictive behaviors 102, 106197, 2020 | 12 | 2020 |
| An assessment of symptom burden in inflammatory bowel diseases to develop a patient preference-weighted symptom score WK van Deen, A Obremskey, G Moore, ME van den Akker-van Marle, ... Quality of Life Research 29, 3387-3396, 2020 | 11 | 2020 |
